473 related articles for article (PubMed ID: 33028177)
1. Validation of the adjusted global antiphospholipid syndrome score in systemic lupus erythematosus patients in Argentina.
Garcia L; Velloso MS; Martire MV; Savy F; Arizpe F; Garcia N; Testi A; Pena C; Costi AC; Isnardi C; Capelusnik D; Mazza S; Curi YS; Collado V; Rodriguez MF; Scarafia S; Pisoni C; de la Torre M; Seewald A; Riva ME; Garcia M
Lupus; 2020 Dec; 29(14):1866-1872. PubMed ID: 33028177
[TBL] [Abstract][Full Text] [Related]
2. Thrombotic risk assessment in antiphospholipid syndrome: do noncriteria antibodies contribute?
Uludağ Ö; Çinar S; McDonnell T; Çene E; Yalçinkaya Y; Gül A; Inanç M; Artim Esen B
Turk J Med Sci; 2023; 53(5):1067-1074. PubMed ID: 38813003
[TBL] [Abstract][Full Text] [Related]
3. Validation of the adjusted global antiphospholipid syndrome score in a single centre cohort of APS patients from Turkey.
Uludağ Ö; Bektaş M; Çene E; Sezer M; Şahinkaya Y; Gül A; Inanç M; Öcal L; Artim-Esen B
J Thromb Thrombolysis; 2021 Feb; 51(2):466-474. PubMed ID: 32588289
[TBL] [Abstract][Full Text] [Related]
4. Thrombotic risk assessment in patients with systemic lupus erythematosus: Validation of the adjusted-Global Antiphospholipid Syndrome Score (aGAPSS) in Thai patients.
Chanloung W; Kasitanon N; Wichainun R; Louthrenoo W
Int J Rheum Dis; 2021 Dec; 24(12):1510-1519. PubMed ID: 34716670
[TBL] [Abstract][Full Text] [Related]
5. Assessing the cardiovascular risk in patients with systemic lupus erythematosus: QRISK and GAPSS scores head-to-head.
Barinotti A; Radin M; Cecchi I; Foddai SG; Arbrile M; Rubini E; Menegatti E; Roccatello D; Sciascia S
Int J Cardiol; 2022 Sep; 363():185-189. PubMed ID: 35714714
[TBL] [Abstract][Full Text] [Related]
6. Adjusted Global Antiphospholipid Syndrome Score (aGAPSS) and PLT, APTT: Predictive Value of Thrombotic Risk Assessment in SLE Patients.
Yu P; Wang H; Li Y; Yang Y; Guo J
Clin Lab; 2024 Jan; 70(1):. PubMed ID: 38213198
[TBL] [Abstract][Full Text] [Related]
7. Independent validation of the adjusted GAPSS: Role of thrombotic risk assessment in the real-life setting.
Fernandez Mosteirin N; Saez Comet L; Salvador Osuna C; Calvo Villas JM; Velilla Marco J
Lupus; 2017 Oct; 26(12):1328-1332. PubMed ID: 28387637
[TBL] [Abstract][Full Text] [Related]
8. The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort.
Radin M; Sciascia S; Erkan D; Pengo V; Tektonidou MG; Ugarte A; Meroni P; Ji L; Belmont HM; Cohen H; Ramires de Jesús G; Branch DW; Fortin PR; Andreoli L; Petri M; Rodriguez E; Rodriguez-Pinto I; Knight JS; Atsumi T; Willis R; Gonzalez E; Lopez-Pedrera R; Rossi Gandara AP; Borges Gualhardo Vendramini M; Banzato A; Sevim E; Barbhaiya M; Efthymiou M; Mackie I; Bertolaccini ML; Andrade D;
Semin Arthritis Rheum; 2019 Dec; 49(3):464-468. PubMed ID: 31153708
[TBL] [Abstract][Full Text] [Related]
9. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
10. Clinical utility of the global anti-phospholipid syndrome score for risk stratification: a pooled analysis.
Sciascia S; Radin M; Sanna G; Cecchi I; Roccatello D; Bertolaccini ML
Rheumatology (Oxford); 2018 Apr; 57(4):661-665. PubMed ID: 29342292
[TBL] [Abstract][Full Text] [Related]
11. GAPSS: the Global Anti-Phospholipid Syndrome Score.
Sciascia S; Sanna G; Murru V; Roccatello D; Khamashta MA; Bertolaccini ML
Rheumatology (Oxford); 2013 Aug; 52(8):1397-403. PubMed ID: 23315788
[TBL] [Abstract][Full Text] [Related]
12. Elevated partial antiphospholipid score is a strong risk factor for thrombosis in patients with systemic lupus erythematosus: a validation study.
Chen J; Sun S; Yan Q; Bao C; Fu Q
Clin Rheumatol; 2016 Feb; 35(2):333-40. PubMed ID: 26753544
[TBL] [Abstract][Full Text] [Related]
13. Global Antiphospholipid Syndrome Score (GAPSS) in Patients with Systemic Lupus Erythematosus.
Cheldieva FA; Reshetnyak TM; Shumilova AA; Nurbaeva KS; Cherkasova MV; Lila AM; Nasonov EL
Dokl Biochem Biophys; 2023 Aug; 511(1):227-234. PubMed ID: 37833610
[TBL] [Abstract][Full Text] [Related]
14. Does Adjusted Global Antiphospholipid Syndrome Score (aGAPSS) Predict the Obstetric Outcome in Antiphospholipid Antibody Carriers? A Single-Center Study.
Del Barrio-Longarela S; Martínez-Taboada VM; Blanco-Olavarri P; Merino A; Riancho-Zarrabeitia L; Comins-Boo A; López-Hoyos M; Hernández JL
Clin Rev Allergy Immunol; 2022 Oct; 63(2):297-310. PubMed ID: 34910282
[TBL] [Abstract][Full Text] [Related]
15. Relevance of non-criteria antiphospholipid antibodies titers among patients with antiphospholipid syndrome and patients with systemic lupus erythematosus.
Urrego-Callejas T; Hernández A; Ruiz Giraldo S; Frade-Sosa B; Vanegas-García AL; Muñoz CH; Rua C; Duque Botero J; González LA; Vásquez G; Gómez-Puerta JA
Reumatol Clin (Engl Ed); 2023 Apr; 19(4):197-203. PubMed ID: 37061281
[TBL] [Abstract][Full Text] [Related]
16. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
[TBL] [Abstract][Full Text] [Related]
17. The adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) for risk stratification in young APS patients with acute myocardial infarction.
Radin M; Schreiber K; Costanzo P; Cecchi I; Roccatello D; Baldovino S; Bazzan M; Cuadrado MJ; Sciascia S
Int J Cardiol; 2017 Aug; 240():72-77. PubMed ID: 28385357
[TBL] [Abstract][Full Text] [Related]
18. Clinical accuracy for diagnosis of antiphospholipid syndrome in systemic lupus erythematosus: evaluation of 23 possible combinations of antiphospholipid antibody specificities.
Sciascia S; Murru V; Sanna G; Roccatello D; Khamashta MA; Bertolaccini ML
J Thromb Haemost; 2012 Dec; 10(12):2512-8. PubMed ID: 23025466
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and clinical correlation of anti-phospholipid-binding protein antibodies in anticardiolipin-negative patients with systemic lupus erythematosus and women with unexplained recurrent miscarriages.
Bizzaro N; Tonutti E; Villalta D; Tampoia M; Tozzoli R
Arch Pathol Lab Med; 2005 Jan; 129(1):61-8. PubMed ID: 15628909
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study.
de Jesús GR; Sciascia S; Andrade D; Barbhaiya M; Tektonidou M; Banzato A; Pengo V; Ji L; Meroni PL; Ugarte A; Cohen H; Branch DW; Andreoli L; Belmont HM; Fortin PR; Petri M; Rodriguez E; Cervera R; Knight JS; Atsumi T; Willis R; Nascimento IS; Rosa R; Erkan D; Levy RA;
BJOG; 2019 Apr; 126(5):656-661. PubMed ID: 30222236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
